Pulmonx Corporation
LUNG
Positions held
Your positionsLUNG isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $77.74M | Enterprise value | $78.10M | Trailing P/E | — | Forward P/E | -1.92 |
| PEG | — | Price / book | 1.98 | Beta | 0.34 | Dividend yield | 0.00% |
| Revenue growth | -4.6% | Earnings growth | — | Gross margin | 77.1% | Operating margin | -39.8% |
| Profit margin | -55.0% | ROE | -88.9% | ROA | -22.1% | Debt / equity | 1.43 |
| Current ratio | 4.32 | Free cash flow | -$11.74M | Analyst recommendation | none | Mean target | $3.40 |
| 52w high | $2.89 | 52w low | $1.13 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $22.8M | $20.6M | $22.6M | $21.5M | $23.9M |
| Op margin | -39.8% | -62.9% | -43.8% | -66.9% | -62.0% |
| Net income | -$10.1M | -$13.7M | -$10.4M | -$14.0M | -$15.2M |
| Gross margin | 78.0% | 77.9% | 77.6% | 74.7% | 72.1% |
| Gross profit | $17.7M | $16.0M | $17.5M | $16.1M | $17.2M |
| Operating income | -$9.1M | -$13.0M | -$9.9M | -$14.4M | -$14.8M |
- Revenue +11% vs prior quarter ($23M vs $21M).
- Gross margin 78% (was 77.9% prior quarter).
- Operating margin expanded to -39.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $90.5M | $83.8M | $68.7M | $53.7M |
| Op margin | -59.3% | -68.9% | -90.2% | -109.3% |
| Net income | -$54.0M | -$56.4M | -$60.8M | -$58.9M |
| Gross margin | 74.2% | 74.0% | 73.9% | 74.3% |
| Gross profit | $67.1M | $62.0M | $50.8M | $39.9M |
| Operating income | -$53.7M | -$57.7M | -$61.9M | -$58.6M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-03 · Pulmonx Shares Fall Following Recent Gains
2026-09-01 · Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-26 · Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy?
2026-08-15 · Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year
2026-08-14 · What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now?
2026-08-08 · Pulmonx (LUNG) Q2 2026 Earnings Call Transcript
2026-08-03 · Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock?
2026-07-30 · Pulmonx Corporation Q2 2026 Earnings Call Summary
2026-07-29 · Pulmonx Q2 Earnings Call Highlights
2026-07-29 · Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
2026-07-29 · Pulmonx Reports Second Quarter 2026 Financial Results
2026-07-28 · Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
Price (daily)
Full chart · RSI · MACD · patterns